Thermo Fisher Scientific Acquires Olink Holding AB
July 10, 2024
Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.
- Targets
- Olink Holding AB (publ)
- Sellers
- Summa Equity
- Industry
- Biotechnology
- Location
- Uppsala County, Sweden
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.